Literature DB >> 23319538

Vaccination site and risk of local reactions in children 1 through 6 years of age.

Lisa A Jackson1, Do Peterson, Jennifer C Nelson, S Michael Marcy, Allison L Naleway, James D Nordin, James G Donahue, Simon J Hambidge, Carolyn Balsbaugh, Roger Baxter, Tracey Marsh, Lawrence Madziwa, Eric Weintraub.   

Abstract

OBJECTIVE: Our objective was to assess whether the occurrence of medically attended local reactions to intramuscularly administered vaccines varies by injection site (arm versus thigh) in children 1 to 6 years of age.
METHODS: This is a retrospective cohort study of children in the Vaccine Safety Datalink population from 2002 to 2009. Site of injection and the outcome of medically attended local reactions were identified from administrative data.
RESULTS: The study cohort of 1.4 million children received 6.0 million intramuscular (IM) vaccines during the study period. The primary analyses evaluated the IM vaccines most commonly administered alone, which included inactivated influenza, hepatitis A, and diphtheria-tetanus-acellular pertussis (DTaP) vaccines. For inactivated influenza and hepatitis A vaccines, local reactions were relatively uncommon, and there was no difference in risk of these events with arm versus thigh injections. The rate of local reactions after DTaP vaccines was higher, and vaccination in the arm was associated with a significantly greater risk of this outcome compared with vaccination in the thigh, both for children 12 to 35 months (relative risk: 1.88 [95% confidence interval: 1.34-2.65]) and 3 to 6 years of age (relative risk: 1.41 [95% confidence interval: 0.84-2.34]), although this difference was not statistically significant in the older age group.
CONCLUSIONS: Injection in the thigh is associated with a significantly lower risk of a medically attended local reaction to a DTaP vaccination among children 12 to 35 months of age, supporting current recommendations to administer IM vaccinations in the thigh for children younger than 3 years of age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319538     DOI: 10.1542/peds.2012-2617

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

2.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.

Authors:  Pedro L Moro; Silvia Perez-Vilar; Paige Lewis; Marthe Bryant-Genevier; Hajime Kamiya; Maria Cano
Journal:  Pediatrics       Date:  2018-06-04       Impact factor: 7.124

3.  DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.

Authors:  Hartono Gunardi; Kusnandi Rusmil; Eddy Fadlyana; Meita Dhamayanti; Rini Sekartini; Rodman Tarigan; Hindra Irawan Satari; Bernie Endyarni Medise; Rini Mulia Sari; Novilia Sjafri Bachtiar; Cissy B Kartasasmita; Sri Rezeki S Hadinegoro
Journal:  BMC Pediatr       Date:  2018-05-28       Impact factor: 2.125

Review 4.  Allergic reactions against Covıd-19 vaccines

Authors:  Hilal Ünsal; Bülent Enis Şekerel; Ümit Murat Şahiner
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.